'' ACID MONOARGININILE SALT (E) -3- [1-N-BUTYL-5- [2,2-PHENY CARBoxy) METHYXY-4-CHLOROPHENYL] -1H-PIRAZOL-4-IL] -2- [( 5-METOXY-2,3-DI-HYDROBENZOFURAN-6-IL) METHIL] -PROP-2-E NONIC '' The present invention relates to a new form of monoargininyl salt of the endothelin receptor antagonist, acid ( E) -3- [1-n-butyl-5- [2- (2-carboxy phenyl) methoxy-4-chlorophenyl] -1H-pyrazol-4-yl] -2- [(5-methoxy-2,3 -dihydrobenzofuran-6-yl) methyl-prop-2-enoic.
展开▼